Drug safety and pharmacovigilance: the major consideration for the pharmaceutical industry

Drug safety and pharmacovigilance: the major consideration for the pharmaceutical industry

Drug safety and pharmacovigilance: the major consideration for the pharmaceutical industryThe 3rd annual World Drug Safety Congress Europe conference brings together top pharmaceutical, biotechnology and regulatory representatives in a forum that addresses the key issues of the industry. For delegatesHealth Network Communications would like to announce the forthcoming World Drug Safety Congress that is taking place in London, United Kingdom in September 2009.This conference follows the huge success of World Drug Safety Congress 2007 and 2008, to which Health Network attracted a record number of drug safety professionals and decision makers to explore the prevalent challenges of today.

The content
The in-depth drug safety conference programme covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences as well as global regulatory coverage of developments in the US, Japan, Europe, Asia/Pacific, South America and Canada.
The speakers
At World Drug Safety Congress Europe you can expect to see speakers from a wide range of countries. There will be case study updates, and we will strive to introduce fresh strategy content as we continue to keep track of the latest developments.